TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomised Study of Automated Versus Mercury Blood Pressure Recordings in Pregnancy
Brief Summary: The aim of the PRAM study was to determine whether women diagnosed with hypertension in pregnancy, using the traditional mercury device, have the same pregnancy outcomes when blood pressure is measured by either an automated device or a mercury device throughout the pregnancy.


Options:
A: Arm Label: Self-Monitoring of Blood Pressure; Type: EXPERIMENTAL; Interventions: Other: Self-Monitoring of Blood Pressure | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Self-Monitoring of Blood Pressure; Assigned to Arm(s): Self-Monitoring of Blood Pressure
B: Arm Label: telemonitoring group (TM); Type: EXPERIMENTAL; Interventions: Device: Telemonitoring | Arm Label: Patient self-monitoring group (PSM); Type: ACTIVE_COMPARATOR; Interventions: Device: Telemonitoring | Arm Label: control group (CC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: CAPROM - Group 1; Type: EXPERIMENTAL; Interventions: Other: Longitudinal CV profiling during pregnancy and before and after the start/switch of antihypertensive medication | Arm Label: CAPROM - Group 2; Type: EXPERIMENTAL; Interventions: Other: CV profiling before and after the start/switch of antihypertensive medication | Intervention Type: DEVICE; Name: Telemonitoring; Assigned to Arm(s): Patient self-monitoring group (PSM), telemonitoring group (TM) | Intervention Type: OTHER; Name: Longitudinal CV profiling during pregnancy and before and after the start/switch of antihypertensive medication; Assigned to Arm(s): CAPROM - Group 1 | Intervention Type: OTHER; Name: CV profiling before and after the start/switch of antihypertensive medication; Assigned to Arm(s): CAPROM - Group 2
C: Arm Label: Mercury; Type: NO_INTERVENTION; Interventions: Device: Automated blood pressure recording device Omron HEM 705CP | Intervention Type: DEVICE; Name: Automated blood pressure recording device Omron HEM 705CP; Assigned to Arm(s): Mercury
D: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: remote monitoring group; Type: EXPERIMENTAL; Interventions: Device: remote monitoring | Intervention Type: DEVICE; Name: remote monitoring; Assigned to Arm(s): remote monitoring group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vitamin D AND Cardiovascular Disease
Brief Summary: In this study the investigators want to compare glucose handling (insulin secretion and insulin sensitivity) in 100 persons with low and 50 persons with normal-high levels of vitamin D, using a hyperglycemic clamp technique, were sugar is given intravenously for 3 hours in order to keep the blood sugar level at 10 mmol/L. Those with low vitamin D levels will be randomized to treatment with vitamin D3 (cholecalciferol) 40 000 IU/week or placebo for 6 months before a new clamp is performed.

The study hypothesis is that persons with low vitamin D levels have impaired glucose handling which might be improved by vitamin D supplementation.


Options:
A: Intervention Type: DRUG; Name: cholecalciferol; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: D-cure | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: D-cure; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: Calcium 500 mg/day and vitamin D 700 IU/day; Assigned to Arm(s): N/A
D: Arm Label: vitamin D2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin D2 | Arm Label: vitamin D3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D2; Assigned to Arm(s): vitamin D2 | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D3; Assigned to Arm(s): vitamin D3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Brief Summary: The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: contingency management and behavioral day treatment; Assigned to Arm(s): N/A
C: Arm Label: cognitive function rehabilitation group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive function rehabilitation and bias modification | Arm Label: cognitive bias modification group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive function rehabilitation and bias modification | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: cognitive function rehabilitation and bias modification; Assigned to Arm(s): cognitive bias modification group, cognitive function rehabilitation group
D: Arm Label: Standard; Type: OTHER; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing | Arm Label: SI/WWE; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam | Arm Label: SI/WWE/PD; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention | Intervention Type: BEHAVIORAL; Name: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing; Assigned to Arm(s): SI/WWE, SI/WWE/PD, Standard | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam; Assigned to Arm(s): SI/WWE | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention; Assigned to Arm(s): SI/WWE/PD

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Brief Summary: The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram, Behavioral: Interpersonal Psychotherapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Escitalopram, Behavioral: Clinical Monitoring | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Interpersonal Psychotherapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Clinical Monitoring; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2
C: Intervention Type: BEHAVIORAL; Name: Control with depression course (CWD); Assigned to Arm(s): N/A
D: Arm Label: Cognitive therapy plus medications; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Therapy, Drug: Medications | Arm Label: Medications alone; Type: EXPERIMENTAL; Interventions: Drug: Medications | Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): Cognitive therapy plus medications | Intervention Type: DRUG; Name: Medications; Assigned to Arm(s): Cognitive therapy plus medications, Medications alone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Brief Summary: The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2
B: Arm Label: Standard; Type: OTHER; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing | Arm Label: SI/WWE; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam | Arm Label: SI/WWE/PD; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention | Intervention Type: BEHAVIORAL; Name: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing; Assigned to Arm(s): SI/WWE, SI/WWE/PD, Standard | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam; Assigned to Arm(s): SI/WWE | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention; Assigned to Arm(s): SI/WWE/PD
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Disulfiram; Type: ACTIVE_COMPARATOR; Interventions: Drug: disulfiram | Arm Label: Placebo plus Contingency Management; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo plus Contingency Management | Arm Label: Disulfiram plus Contingency Management; Type: ACTIVE_COMPARATOR; Interventions: Drug: Disulfiram plus Contingency Management | Intervention Type: DRUG; Name: disulfiram; Assigned to Arm(s): Disulfiram | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Placebo plus Contingency Management; Assigned to Arm(s): Placebo plus Contingency Management | Intervention Type: DRUG; Name: Disulfiram plus Contingency Management; Assigned to Arm(s): Disulfiram plus Contingency Management
D: Intervention Type: BEHAVIORAL; Name: contingency management and behavioral day treatment; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Brief Summary: The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.


Options:
A: Arm Label: Traditional Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Traditional Contingency Management | Arm Label: Early Enhanced Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Early Enhanced Contingency Management | Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Treatment | Intervention Type: BEHAVIORAL; Name: Standard Treatment; Assigned to Arm(s): Standard Treatment | Intervention Type: BEHAVIORAL; Name: Traditional Contingency Management; Assigned to Arm(s): Traditional Contingency Management | Intervention Type: BEHAVIORAL; Name: Early Enhanced Contingency Management; Assigned to Arm(s): Early Enhanced Contingency Management
B: Arm Label: CBT-AD; Type: EXPERIMENTAL; Interventions: Behavioral: CBT-AD | Arm Label: ETAU; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ETAU | Intervention Type: BEHAVIORAL; Name: CBT-AD; Assigned to Arm(s): CBT-AD | Intervention Type: BEHAVIORAL; Name: ETAU; Assigned to Arm(s): ETAU
C: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Communities That Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communities That Care | Intervention Type: BEHAVIORAL; Name: Communities That Care; Assigned to Arm(s): Communities That Care Intervention
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Brief Summary: The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.


Options:
A: Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): N/A
B: Arm Label: Smoking-cessation treatment + substance treatment as usual; Type: EXPERIMENTAL; Interventions: Other: Smoking-cessation treatment | Arm Label: Substance-treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Smoking-cessation treatment; Assigned to Arm(s): Smoking-cessation treatment + substance treatment as usual
C: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Arm Label: E-cigarette free access; Type: EXPERIMENTAL; Interventions: Behavioral: E-cigarette free access | Arm Label: E-cigarette/NRT/Zyban/Chantix Choice; Type: EXPERIMENTAL; Interventions: Behavioral: E-cigarette/NRT/Zyban/Chantix Choice | Arm Label: Outcome Incentive arm; Type: EXPERIMENTAL; Interventions: Behavioral: Outcome Incentive arm | Arm Label: Loss framing incentive arm; Type: EXPERIMENTAL; Interventions: Behavioral: Loss framing incentive arm | Intervention Type: BEHAVIORAL; Name: E-cigarette free access; Assigned to Arm(s): E-cigarette free access | Intervention Type: BEHAVIORAL; Name: E-cigarette/NRT/Zyban/Chantix Choice; Assigned to Arm(s): E-cigarette/NRT/Zyban/Chantix Choice | Intervention Type: BEHAVIORAL; Name: Outcome Incentive arm; Assigned to Arm(s): Outcome Incentive arm | Intervention Type: BEHAVIORAL; Name: Loss framing incentive arm; Assigned to Arm(s): Loss framing incentive arm | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Brief Summary: The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.


Options:
A: Arm Label: Case management; Type: EXPERIMENTAL; Interventions: Behavioral: Case management | Arm Label: Enhanced usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced usual care | Intervention Type: BEHAVIORAL; Name: Case management; Assigned to Arm(s): Case management | Intervention Type: OTHER; Name: Enhanced usual care; Assigned to Arm(s): Enhanced usual care
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Assertive intervention | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard treatment | Intervention Type: BEHAVIORAL; Name: Assertive intervention; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Standard treatment; Assigned to Arm(s): B
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2
D: Arm Label: 5 year; Type: EXPERIMENTAL; Interventions: Behavioral: OPUS 5 years | Arm Label: 2 years of OPUS treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 2 years OPUS treatment | Intervention Type: BEHAVIORAL; Name: 2 years OPUS treatment; Assigned to Arm(s): 2 years of OPUS treatment | Intervention Type: BEHAVIORAL; Name: OPUS 5 years; Assigned to Arm(s): 5 year

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Brief Summary: The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2
B: Arm Label: CET/PT; Type: EXPERIMENTAL; Interventions: Behavioral: CET/PT | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: CET/PT; Assigned to Arm(s): CET/PT | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual
C: Arm Label: motivational interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing, Other: Treatment as usual | Arm Label: control group; Type: OTHER; Interventions: Other: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): motivational interviewing | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): control group, motivational interviewing
D: Intervention Type: BEHAVIORAL; Name: Behavior Therapy; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals
Brief Summary: We are testing to see if Galantamine, a learning enhancing medication, will help methadone maintained cocaine abusers with their learning and memory specific to CBT using an innovative CBT computer program.


Options:
A: Arm Label: Standard Treatment As Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TAU Plus Galantamine; Type: EXPERIMENTAL; Interventions: Drug: Galantamine | Arm Label: TAU plus Computer Assisted Cognitive Behavioral Therapy (CBT); Type: EXPERIMENTAL; Interventions: Behavioral: Computer Assisted Cognitive Behavioral Therapy (CBT) | Arm Label: TAU plus CBT plus galantamine; Type: EXPERIMENTAL; Interventions: Drug: Galantamine, Behavioral: Computer Assisted Cognitive Behavioral Therapy (CBT) | Intervention Type: DRUG; Name: Galantamine; Assigned to Arm(s): TAU Plus Galantamine, TAU plus CBT plus galantamine | Intervention Type: BEHAVIORAL; Name: Computer Assisted Cognitive Behavioral Therapy (CBT); Assigned to Arm(s): TAU plus CBT plus galantamine, TAU plus Computer Assisted Cognitive Behavioral Therapy (CBT)
B: Arm Label: cognitive function rehabilitation group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive function rehabilitation and bias modification | Arm Label: cognitive bias modification group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive function rehabilitation and bias modification | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: cognitive function rehabilitation and bias modification; Assigned to Arm(s): cognitive bias modification group, cognitive function rehabilitation group
C: Arm Label: Standard; Type: OTHER; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing | Arm Label: SI/WWE; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam | Arm Label: SI/WWE/PD; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention | Intervention Type: BEHAVIORAL; Name: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing; Assigned to Arm(s): SI/WWE, SI/WWE/PD, Standard | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam; Assigned to Arm(s): SI/WWE | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention; Assigned to Arm(s): SI/WWE/PD
D: Arm Label: Referral to community resources; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency management | Intervention Type: BEHAVIORAL; Name: Contingency management; Assigned to Arm(s): Contingency Management

Answer: A